Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/75252/000007525219000129/omi9302019-10q.htm
August 2022
July 2022
June 2022
May 2022
May 2022
May 2022
April 2022
April 2022
March 2022
March 2022
Financial Summary | YTD | YTD | ||
($ in millions, except per share data) | 3Q19 | 3Q18 | 2019 | 2018 |
Revenue | $2,399 | $2,465 | $7,345 | $7,296 |
Operating income, GAAP1,2 | $25.3 | $21.4 | $56.2 | ($126) |
Adj. Operating income, Non-GAAP1,2 | $42.3 | $48.8 | $109 | $143 |
Net income (loss), GAAP1,2 | $1.2 | ($0.6) | ($23.3) | ($175) |
Adj. Net income, Non-GAAP1,2 | $12.2 | $19.5 | $19.3 | $65.1 |
Net Income (loss) per share, GAAP1,2 | $0.02 | ($0.01) | ($0.39) | ($2.92) |
Adj. Net Income per share, Non-GAAP1,2 | $0.20 | $0.32 | $0.32 | $1.06 |
Adj. Net Income per share, Non-GAAP, constant currency1,2,3 | $0.22 | $0.32 | $0.34 | $1.06 |
1. Reconciliations of the differences between the non-GAAP financial measures presented in this news release and their most directly comparable GAAP financial measures are included in the financial tables below. 2. Year-to-date comparisons to prior year results are impacted by the second quarter 2018 goodwill and intangible asset impairment charge of $165 million, or $2.73 per share. This charge was classified as a non-GAAP item and, accordingly, did not affect results reported on an adjusted basis. 3. Adjusted net income per share, non-GAAP at 2018 foreign currency exchange rates. |
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/75252/000007525219000129/omi9302019-10q.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Owens Minor Inc.
Owens Minor Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:
Rating
Learn More![]()
We believe available financing sources, including cash generated by operating activities and borrowings under the Credit Agreement, will be sufficient to fund our working capital needs, capital expenditures, long-term strategic growth, payments under long-term debt and lease arrangements, payments of quarterly cash dividends, share repurchases and other cash requirements.
Adjusted operating income, adjusted net income and adjusted EPS are an alternative view of performance used by management, and we believe that investors' understanding of our performance is enhanced by disclosing these performance measures.
Gross margin in the three and nine months ended September 30, 2019, reflected overall improved sales mix, as the products and manufacturer solutions revenues constitute a higher percentage of revenue, which was partially offset by unfavorable impact from foreign currency translation of $5.3 million and $19.1 million, respectively.
Our Board of Directors authorized a share repurchase program of up to $100 million of our outstanding common stock to be executed at the discretion of management over a three-year period, expiring in December 2019.
Cash (used for) provided by financing activities in the first nine months of 2019 included dividend payments of $5.1 million and repayments of $36.1 million under our revolving credit facility, compared to dividend payments of $32.2 million and proceeds from borrowings of $74.8 million for the same period of 2018.
Global Solutions operating income of...Read more
We entered into transition services...Read more
Although we believe our expectations...Read more
Overall DS&A expenses compared to...Read more
Global Products operating income was...Read more
These were partially offset by...Read more
At September 30, 2019 and...Read more
On a year to date...Read more
Other (income) expense, net in...Read more
Interest expense increased year over...Read more
The following table provides a...Read more
In general, the measures exclude...Read more
We monitor operating working capital...Read more
The second and third quarters...Read more
Financing activities in the first...Read more
The non-GAAP financial measures disclosed...Read more
The Credit Agreement provides a...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
Owens Minor Inc provided additional information to their SEC Filing as exhibits
Ticker: OMI
CIK: 75252
Form Type: 10-Q Quarterly Report
Accession Number: 0000075252-19-000129
Submitted to the SEC: Wed Nov 06 2019 11:45:17 AM EST
Accepted by the SEC: Wed Nov 06 2019
Period: Monday, September 30, 2019
Industry: Wholesale Medical Dental And Hospital Equipment And Supplies